{"id":139,"date":"2023-08-22T11:57:50","date_gmt":"2023-08-22T11:57:50","guid":{"rendered":"https:\/\/www.lundhjemmesider-udvikling.dk\/rgbg\/?page_id=139"},"modified":"2026-03-12T15:23:51","modified_gmt":"2026-03-12T13:23:51","slug":"om-rbgb","status":"publish","type":"page","link":"https:\/\/www.rbgb.dk\/en\/om-rbgb\/","title":{"rendered":"About RBGB"},"content":{"rendered":"<div class=\"grve-section grve-row-section grve-fullwidth grve-padding-top-2x grve-padding-bottom-1x grve-with-bg-image grve-bg-fixed\" data-header-color=\"default\"><div class=\"grve-container\"><div class=\"grve-row grve-bookmark grve-columns-gap-default grve-mobile-vertical-gap-30\"><div class=\"grve-column wpb_column grve-bookmark grve-column-1-12  grve-with-bg-transparent grve-empty-column\"><div class=\"grve-column-wrapper\"><div class=\"grve-column-content\" ><\/div><\/div><\/div><div class=\"grve-column wpb_column grve-bookmark grve-column-1-3  grve-with-bg-transparent\"  style=\"color:#ffffff;\"><div class=\"grve-column-wrapper\"><div class=\"grve-column-content\" ><div class=\"grve-empty-space grve-height-5x\"><\/div><div class=\"grve-empty-space grve-height-5x\"><\/div><h1 class=\"grve-element grve-title grve-align-left grve-feature-title grve-increase-heading grve-heading-140 grve-text-white page_title\"><span>About RBGB<\/span><\/h1><div class=\"grve-empty-space grve-height-1x\"><\/div><\/div><\/div><\/div><div class=\"grve-column wpb_column grve-bookmark grve-column-1-3  grve-with-bg-transparent grve-empty-column\"><div class=\"grve-column-wrapper\"><div class=\"grve-column-content\" ><\/div><\/div><\/div><\/div><\/div><div class=\"grve-background-wrapper\">  <div class=\"grve-bg-image grve-bg-image-id-145\"   style=\"background-image: url(https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/P1288467_16_9_flipped.jpg);\"><\/div>  <div class=\"grve-bg-overlay grve-bg-black grve-opacity-30\"><\/div><\/div><\/div><div class=\"grve-section grve-row-section grve-fullwidth-background grve-with-bg-color\" data-header-color=\"default\"  style=\"background-color:#99095f;color:#ffffff;padding-top: 8px;padding-bottom: 8px;\"><div class=\"grve-container\"><div class=\"grve-row grve-bookmark grve-columns-gap-default grve-mobile-vertical-gap-30\"><div class=\"grve-column wpb_column grve-bookmark grve-column-1  grve-with-bg-transparent\"><div class=\"grve-column-wrapper\"><div class=\"grve-column-content\" ><div class=\"grve-element grve-text\">\r\n\t\t\t\r\n\t\t<\/div>\r\n\t<\/div><\/div><\/div><\/div><\/div><\/div><div class=\"grve-section grve-row-section grve-fullwidth-background grve-padding-top-2x grve-with-bg-transparent grve-equal-columns\" data-header-color=\"default\"><div class=\"grve-container\"><div class=\"grve-row grve-bookmark grve-columns-gap-default grve-mobile-vertical-gap-30\"><div class=\"grve-column wpb_column grve-bookmark grve-column-1  grve-with-bg-transparent\"><div class=\"grve-column-wrapper\"><div class=\"grve-column-content\" ><h3 class=\"grve-element grve-title grve-align-center grve-h3\"><span><br>\n<h3>Introduction to Bio- and Genome Bank Denmark (RBGB)<\/h3>\n<\/span><\/h3><div class=\"grve-empty-space grve-height-1x\"><\/div><div class=\"grve-element grve-text vc_custom_1758783898500\">\r\n\t\t\t<p style=\"text-align: center;\">The Danish Regions\u2019 Bio- and Genome Bank is the collective term for a number of clinical biobanks within various disease areas, as well as a donor biobank and a research biobank.\n\nWatch the video below, where Leif Panduro Jensen (former Chair of the Steering Committee for RBGB) and Estrid H\u00f8gdall (Director of RBGB and Professor) talk about RBGB.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/div><\/div><\/div><\/div><\/div><div class=\"grve-section grve-row-section grve-fullwidth-background grve-padding-top-2x grve-with-bg-transparent\" data-header-color=\"default\"><div class=\"grve-container\"><div class=\"grve-row grve-bookmark grve-columns-gap-default grve-mobile-vertical-gap-30\"><div class=\"grve-column wpb_column grve-bookmark grve-column-1 grve-wpb-1706518991745 grve-horizontal-position-center grve-with-bg-transparent grve-custom-width-50\"><div class=\"grve-column-wrapper\"><div class=\"grve-column-content\" ><video class=\"grve-element grve-embed-video\" controls poster=\"https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Skaermbillede-Hvad-er-RBGB.png\"><source src=\"https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Hvad-er-RBGB.mov\" type=\"video\/mp4\"><\/video><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"grve-section grve-row-section grve-fullwidth-background grve-padding-top-1x grve-padding-bottom-1x grve-with-bg-transparent\" data-header-color=\"default\"><div class=\"grve-container\"><div class=\"grve-row grve-bookmark grve-columns-gap-default grve-mobile-vertical-gap-30\"><div class=\"grve-column wpb_column grve-bookmark grve-column-1  grve-with-bg-transparent\"><div class=\"grve-column-wrapper\"><div class=\"grve-column-content\" ><div class=\"grve-empty-space grve-height-1x\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<p style=\"text-align: center;\">You can read more about the individual biobanks within RBGB in the descriptions below:<\/p>\n\r\n\t\t<\/div>\r\n\t<div class=\"grve-empty-space grve-height-1x\"><\/div><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"grve-section grve-row-section grve-fullwidth-background grve-padding-bottom-4x grve-with-bg-transparent\" data-header-color=\"default\"><div class=\"grve-container\"><div class=\"grve-row grve-bookmark grve-columns-gap-default grve-mobile-vertical-gap-30\"><div class=\"grve-column wpb_column grve-bookmark grve-column-1  grve-with-bg-transparent\"><div class=\"grve-column-wrapper\"><div class=\"grve-column-content\" ><div class=\"grve-element grve-accordion  vc_custom_1706519876296\"><ul class=\"grve-accordion-wrapper grve-action-toggle grve-with-icon\"><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1692872810059-cb778af0-bfd4\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Blood Donor Biobank (DBB)<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1692872810059-cb778af0-bfd4\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<h5>About us<\/h5>\n<p>The Danish Blood Donor Biobank (DBB) collects and stores blood samples from donors who have agreed to participate in the research project, The Danish Blood Donor Study (DBDS). The inventory of the biobank consists of residual blood samples procedurally drawn as a part of donating blood. When a participant is included in the research project, a sample of whole blood is stored, and the DNA is purified for a comprehensive genetic analysis (Infinium\u00ae Global Screening Array (GSA), Illumina). An aliquot of plasma is stored at the time of inclusion and every time a participant donates, termed longitudinal samples. The longitudinal samples enable researchers to measure the change in biological markers over time.<\/p>\n\r\n\t\t<\/div>\r\n\t<div style=\"height: 40px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-image-text grve-style-1 grve-position-right\"><div class=\"grve-image grve-radius-10\"><div class=\"grve-thumbnail-wrapper\"><div class=\"grve-thumbnail\"  style=\"padding-top: 60.286%;\"><img loading=\"lazy\" decoding=\"async\" width=\"768\" height=\"463\" src=\"https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/DBDS-flow-768x463.png\" class=\"attachment-medium_large size-medium_large\" alt=\"Overblik over indsamling og opbevaring af blodpr\u00f8ver i DBB fra 1) inklusion til DNA og biokemiske analyser eller 2) forl\u00f8bspr\u00f8ver til biokemiske analyser\" data-column-space=\"100\" data-lazyload=\"\" data-grve-filter=\"yes\" srcset=\"https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/DBDS-flow-768x463.png 768w, https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/DBDS-flow-300x181.png 300w, https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/DBDS-flow-1024x617.png 1024w, https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/DBDS-flow.png 1027w\" sizes=\"auto, (max-width: 768px) 100vw, 768px\" \/><\/div><\/div><\/div><div class=\"grve-content grve-align-left\"><div class=\"grve-content-inner\"><h5 class=\"grve-title grve-h6\">The Danish Blood Donor Study (DBDS)<\/h5><p class=\"grve-description\">DBDS is a research project meant to provide new knowledge on the health effects of donating blood and insights into diseases of the general population. DBDS was started in 2010 in the blood banks of the Capital Region and the Region of Central Jutland. It has since become national. And today, DBDS has 130,000 blood donors and provides the largest genetic control population in Denmark.<\/p>\n<p>When blood donors choose to participate in the DBDS, they fill out an electronic form on phenotypes. Subsequently, they can be asked whether they will fill out new forms, continuously developed by DBDS. In addition, DBDS has approval to use the registry data.<\/p><\/div><\/div><\/div><div style=\"height: 40px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-inner-section grve-with-bg-transparent\"><div class=\"grve-row-inner grve-bookmark grve-columns-gap-default grve-mobile-vertical-gap-30\"><div class=\"grve-column-inner wpb_column grve-column-1-2  grve-with-bg-transparent\"><div class=\"grve-column-wrapper-inner\"><div class=\"grve-column-inner-content\" ><div style=\"height: 17px;\" class=\"grve-empty-space\"><\/div><video class=\"grve-element grve-embed-video\" style=\"margin-bottom: 10%;\" controls><source src=\"https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Hvad-er-DBDS.mp4\" type=\"video\/mp4\"><\/video><\/div><\/div><\/div><div class=\"grve-column-inner wpb_column grve-column-1-2  grve-with-bg-transparent\"><div class=\"grve-column-wrapper-inner\"><div class=\"grve-column-inner-content\" ><div class=\"grve-element grve-fancy-box grve-align-left grve-radius-10\"><div class=\"grve-fancy-box-inner\"><div class=\"grve-title grve-heading-color grve-leader-text\" style=\"\">The vision for the Danish Blood Donor Study is the blood donors will donate blood and life to current patients and knowledge to future patients.<\/div><div class=\"grve-link-text grve-fancy-box-read-more\">https:\/\/DBDS.dk<\/div>  <\/div><a href=\"https:\/\/bloddonor.dk\/bloddonorstudiet\/dbds\/\" target=\"_blank\" class=\"grve-item-url\"><\/a><div class=\"grve-fancy-box-bg grve-bg-primary-2 grve-radius-10\"><\/div><\/div><\/div><\/div><\/div><\/div><\/div><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<h5><strong>The Danish Blood Banks<\/strong><\/h5>\n<p>The blood banks employ a well-trained and motivated staff who handles the daily registration of blood donors, the blood sampling, and the daily management of the blood banks. By using the blood bank infrastructure, the largest health scientific examination of healthy people in Denmark is carried out at a low cost creating a resource for national research in public health, disease etiology, diagnostics and treatment.<\/p>\n\r\n\t\t<\/div>\r\n\t<div style=\"height: 40px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<h5>Blood Donors Denmark<\/h5>\n<p>Blood Donors Denmark is responsible for acknowledging the 180,000 Danish volunteer blood donors. The organization is built around voluntarism and has 500 volunteer staff members working to secure a stable blood supply in Denmark alongside the five regional blood banks. For more information: <a href=\"https:\/\/bloddonor.dk\/\">bloddonor.dk<\/a><\/p>\n\r\n\t\t<\/div>\r\n\t<div style=\"height: 40px;\" class=\"grve-empty-space\"><\/div><\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1692874175698-e989a46e-81b1\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Cancer Biobank (DCB)<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1692874175698-e989a46e-81b1\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<h5>Organisation<strong><br \/>\n<\/strong><\/h5>\n<p>The Danish Cancer Biobank is a clinical biobank organized in six biobank centers located in Herlev, N\u00e6stved, Odense, the National Hospital, Aalborg, and Aarhus. The biobank centers coordinate the regional biobank tasks and responsibilities: contact with the biospecimen collection departments, contact with researchers, biospecimen registration, freezer storage tasks, and biospecimen transfers and distribution.<\/p>\n<h5>Clinical Data Sources<strong><br \/>\n<\/strong><\/h5>\n<p>The Danish Cancer Biobank has its own national laboratory information management system (LIMS) which is linked to the clinical database, PGDB. This means that collected biospecimen can be complemented by diagnostic data. Furthermore, it is possible to connect the biospecimen to the civil registration number registry and the Danish Multidisciplinary Cancer Groups (DMCG).<\/p>\n\r\n\t\t<\/div>\r\n\t<div style=\"height: 40px;\" class=\"grve-empty-space\"><\/div><div style=\"height: 40px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-inner-section grve-with-bg-transparent\"><div class=\"grve-row-inner grve-bookmark grve-columns-gap-default grve-mobile-vertical-gap-30\"><div class=\"grve-column-inner wpb_column grve-column-1-2  grve-with-bg-transparent\"><div class=\"grve-column-wrapper-inner\"><div class=\"grve-column-inner-content\" ><video class=\"grve-element grve-embed-video\" controls><source src=\"https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Hvad-er-DCB.mov\" type=\"video\/mp4\"><\/video><\/div><\/div><\/div><div class=\"grve-column-inner wpb_column grve-column-1-2  grve-with-bg-transparent\"><div class=\"grve-column-wrapper-inner\"><div class=\"grve-column-inner-content\" ><div style=\"height: 40px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<h5><strong>Target Group<br \/>\n<\/strong><\/h5>\n<p>The target group for the collection of biospecimen for the Danish Cancer Biobank is patients with a cancer diagnosis. Tissue is typically collected in conjunction with surgery and blood samples are routinely taken before any surgical procedure. But a lot of research projects are involved in the follow-up procedures where blood or other types of biospecimen are also collected.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/div><\/div><\/div><\/div><div style=\"height: 40px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<h5><strong>Background<br \/>\n<\/strong><\/h5>\n<p>In \u201cCancer Plan 2\u201d (2005) an infrastructure for clinical cancer research was recommended, which in 2007 led to the Ministry of Interior and Health establishing an infrastructure fund. Also, in 2007 a number of pathology and clinical biochemical departments collaborated on an application which led to the establishment of the Danish Cancer Biobank. In the Danish Cancer Biobank there is a national collection of biospecimen primarily for research but also to supplement Patobank with frozen biospecimens. From 2010 all Danish Regions became active as contributors of this collection. The Danish Cancer Biobank receives annual grants from the Danish Regions to cover their expenses running the biobank.<\/p>\n\r\n\t\t<\/div>\r\n\t<div style=\"height: 40px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-inner-section grve-with-bg-transparent\"><div class=\"grve-row-inner grve-bookmark grve-columns-gap-default grve-mobile-vertical-gap-30\"><div class=\"grve-column-inner wpb_column grve-column-1-2  grve-with-bg-transparent\"><div class=\"grve-column-wrapper-inner\"><div class=\"grve-column-inner-content\" ><div class=\"grve-element grve-text\">\r\n\t\t\t<h5><strong>Perspective and Vision<br \/>\n<\/strong><\/h5>\n<p>The goal for the Danish Cancer Biobank is to strengthen the infrastructure for clinical cancer research and transfer biospecimens for supplementary diagnostics. This is effectuated through standardized sampling, that ensure a similar quality; trained staff, who process the biospecimen; good coverage of the many different varieties of cancer; a simple workflow for the researchers who contact the biobank regarding their specific research project.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/div><\/div><div class=\"grve-column-inner wpb_column grve-column-1-2  grve-with-bg-transparent\"><div class=\"grve-column-wrapper-inner\"><div class=\"grve-column-inner-content\" ><div class=\"grve-element grve-image grve-align-center\">\r\n\t<div class=\"grve-image-item\">\r\n\t\t\r\n\r\n<div class=\"grve-image-wrapper grve-no-effect\">\r\n\t\t<div class=\"grve-thumbnail-wrapper\"  style=\"width: 1914px;\"><div class=\"grve-thumbnail\"  style=\"padding-top: 45.037%;\"><img loading=\"lazy\" decoding=\"async\" width=\"1914\" height=\"862\" src=\"https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Breast-Cancer-HE-20x-TMA.jpg\" class=\"attachment-full size-full\" alt=\"\" data-column-space=\"auto\" data-lazyload=\"\" data-grve-filter=\"yes\" srcset=\"https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Breast-Cancer-HE-20x-TMA.jpg 1914w, https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Breast-Cancer-HE-20x-TMA-300x135.jpg 300w, https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Breast-Cancer-HE-20x-TMA-1024x461.jpg 1024w, https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Breast-Cancer-HE-20x-TMA-768x346.jpg 768w, https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Breast-Cancer-HE-20x-TMA-1536x692.jpg 1536w\" sizes=\"auto, (max-width: 1914px) 100vw, 1914px\" \/><\/div><\/div>\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<\/div><\/div><\/div><\/div><\/div><div style=\"height: 40px;\" class=\"grve-empty-space\"><\/div><\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1692874174907-5c354877-7174\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Covid-19 Biobank (D19B)<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1692874174907-5c354877-7174\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-inner-section grve-with-bg-transparent\"><div class=\"grve-row-inner grve-bookmark grve-columns-gap-default grve-mobile-vertical-gap-30\"><div class=\"grve-column-inner wpb_column grve-column-1-2  grve-with-bg-transparent\"><div class=\"grve-column-wrapper-inner\"><div class=\"grve-column-inner-content\" ><div class=\"grve-element grve-text\">\r\n\t\t\t<h5>The Danish Covid-19 Biobank<\/h5>\n<p>During the hectic days of Denmark\u2019s lockdown in March 2020, researchers affiliated with Bio- and GenomeBank Denmark (RBGB) recognized a unique opportunity to collect biological material to study multiple aspects of the pandemic. To support pandemic-related research, a nationwide clinical biobank was rapidly established. Approval and support were secured from RBGB\u2019s steering committee and regional directors, reflecting the urgent need for thorough investigation. The first samples were registered in the biobank on March 25, 2020, and included blood from healthy individuals, suspected COVID-19 cases, and patients with mild, moderate, or severe COVID-19.<\/p>\n<p>Collaborations were established across hospital departments and with private partners. There was a strong emphasis on knowledge sharing and transparency in order to gain as much insight as possible, as quickly as possible. Research based on material from the Danish Covid-19 Biobank has included analyses of Covid antigens, antibodies, and viral RNA, as well as other biomarkers related to the disease\u2019s diagnosis and prognosis.<\/p>\n<p>The biobank played a central role in Denmark\u2019s response to the pandemic. Sample collection has, for the time being, been concluded, but the biobank continues to serve as an important archival resource, and collection can be resumed if there is a need for new samples.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/div><\/div><div class=\"grve-column-inner wpb_column grve-column-1-2  grve-with-bg-transparent\"><div class=\"grve-column-wrapper-inner\"><div class=\"grve-column-inner-content\" ><div style=\"height: 85px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-image grve-align-center\">\r\n\t<div class=\"grve-image-item\">\r\n\t\t\r\n\r\n<div class=\"grve-image-wrapper grve-no-effect\">\r\n\t\t<div class=\"grve-thumbnail-wrapper\"  style=\"width: 2560px;\"><div class=\"grve-thumbnail\"  style=\"padding-top: 66.68%;\"><img loading=\"lazy\" decoding=\"async\" width=\"2560\" height=\"1707\" src=\"https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Herlev-hospital-2017HI3Q3646-scaled.jpg\" class=\"attachment-full size-full\" alt=\"\" data-column-space=\"auto\" data-lazyload=\"\" data-grve-filter=\"yes\" srcset=\"https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Herlev-hospital-2017HI3Q3646-scaled.jpg 2560w, https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Herlev-hospital-2017HI3Q3646-300x200.jpg 300w, https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Herlev-hospital-2017HI3Q3646-1024x683.jpg 1024w, https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Herlev-hospital-2017HI3Q3646-768x512.jpg 768w, https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Herlev-hospital-2017HI3Q3646-1536x1024.jpg 1536w, https:\/\/www.rbgb.dk\/wp-content\/uploads\/2023\/08\/Herlev-hospital-2017HI3Q3646-1920x1280.jpg 1920w\" sizes=\"auto, (max-width: 2560px) 100vw, 2560px\" \/><\/div><\/div>\t<\/div>\r\n\t<\/div>\r\n<\/div>\r\n<\/div><\/div><\/div><\/div><\/div><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1692874069715-2693d351-00b3\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Derma Biobank (DDeB)<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1692874069715-2693d351-00b3\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<p>Since February 2022, the Danish Derma Biobank (DDeB) has been collecting samples from patients with inflammatory skin diseases such as psoriasis, atopic dermatitis, and contact dermatitis for long-term storage.<\/p>\n<p>The research project BIOSKIN makes use of the Danish Derma Biobank. The aim of the BIOSKIN project is to increase understanding of how inflammatory skin diseases develop over time \u2013 with the goal of improving patient care through both prevention and personalized medicine. The research team at the Dermato-Allergic Department, Herlev-Gentofte Hospital, collects data through clinical studies, including skin and blood samples from a total of 1,000 patients in each disease group.<\/p>\n<p>Recruitment takes place primarily among patients referred to the department, but also through patient associations and general practitioners. Patients participating in BIOSKIN via the Danish Derma Biobank are followed for a minimum of five years.<\/p>\n<p>Read more about the project at <a style=\"color: #0000ee;\" href=\"http:\/\/www.bioskin.dk\">www.bioskin.dk.<\/a><\/p>\n<p>Going forward, the ambition is to further develop the biobank by involving additional research projects. DDeB is not a national biobank at present, but as part of its ongoing development, it is a goal to establish a Scientific Advisory Board for the biobank.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1692874067837-39c69f0a-cdcd\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Diabetes Biobank (DDB)<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1692874067837-39c69f0a-cdcd\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<p>The Danish Diabetes Biobank (DDB) is part of RBGB\u2019s national infrastructure, which supports clinical biobanks for research purposes. The biobank contributes to advancing Danish diabetes research and enhancing opportunities for improved patient care.<\/p>\n<p>The Danish Diabetes Biobank currently supports 8 research projects, and efforts are continuously being made to expand this number. In this way, the biobank ensures an ongoing contribution to important Danish research and creates value for future patient care.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1713268952104-c26fc245-1580\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Endocrinological Biobank (DEB)<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1713268952104-c26fc245-1580\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<p>The Danish Endocrinological Biobank (DEB) has been established as part of the RBGB infrastructure with the aim of strengthening and supporting research in endocrinology.<\/p>\n<p>Currently, DEB houses samples from the LightCOM project, which includes three clinical intervention studies, one of which involves national sample collection. The project also has an international perspective, collaborating with research groups in the United Kingdom. Read more about LightCOM at their <a style=\"color: #0000ee;\" href=\"https:\/\/www.regionh.dk\/lightcom\/sider\/default.aspx\">website<\/a>.<\/p>\n<p>With the establishment of the Danish Endocrinological Biobank, a solid foundation is created for clinical studies and future research projects in endocrinology, with the ambition that the biobank can develop into a central resource for both national and international collaborations.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1692715019840-de62a3ac-8477\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Research Biobank<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1692715019840-de62a3ac-8477\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<p>The Danish Research Biobank (DFB) was established to support research projects that are not conducted for clinical purposes. The biobank therefore houses biological material collected in connection with a specific health science research project approved by VEK.<\/p>\n<p>The DFB currently supports 9 research projects.<\/p>\n<p>It should be noted that there are costs associated with sample collection within the RBGB infrastructure for projects in the Danish Research Biobank. The price depends on the number of centers and local departments involved and is determined individually for each project.<\/p>\n<p>For further information and guidance, please contact the RBGB Secretariat.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1713268784960-34d9757f-8ab2\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Genetic Biobank (DGB)<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1713268784960-34d9757f-8ab2\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<p>In 2020, Danish Regions decided to expand the national biobank infrastructure with a biobank for genetic samples: the Danish Genetic Biobank (DGB).<\/p>\n<p>The purpose of the biobank is to create a unified infrastructure for registering and tracking samples used for genetic analyses \u2013 primarily DNA and RNA extracted in molecular biology laboratories. An additional goal is to establish a nationwide registry of samples used for genetic analyses across Denmark.<\/p>\n<p>To ensure scientific guidance, a Scientific Advisory Board has been established for DGB, with representation from the six clinical genetics departments in the country.<\/p>\n<p>The RBGB Secretariat provides ongoing support and guidance to the departments, and in the future, the RBGB registry will offer a national overview of samples used for genetic counseling in Denmark.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1772019129041-95e529f1-f671\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Heart Biobank (DHB)<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1772019129041-95e529f1-f671\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<p>In 2025, RBGB was expanded to include the clinical Danish Heart Biobank (DHB).<\/p>\n<p>The purpose of the biobank is to establish a unified infrastructure for registering and tracking samples used within the field of cardiology.<\/p>\n<p>The national research project CAPTURE uses the Danish Heart Biobank for the collection, registration, and storage of biological material obtained from up to 30,000 individuals with risk factors and symptoms consistent with heart failure with preserved ejection fraction (HFpEF).<\/p>\n<p>Read more about the project at <a href=\"https:\/\/www.herlevhospital.dk\/capture-heart\/om-capture\/sider\/default.aspx\">https:\/\/www.herlevhospital.dk\/capture-heart\/om-capture\/sider\/default.aspx<\/a><\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1773320818372-cf019109-daf1\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Nephro Biobank<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1773320818372-cf019109-daf1\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<p>In 2023, RBGB was expanded to include the clinical Danish Nephro Biobank (DNB).<\/p>\n<p>Historically, the diagnosis of primary medical kidney diseases has required a kidney biopsy, which is an invasive procedure that involves time consumption and patient discomfort or pain, as well as risks of complications.<\/p>\n<p>In recent years, new diagnostic biomarkers have been introduced in the field of medical kidney diseases. For example, PLA2R antibodies can be used in the diagnosis of membranous glomerulonephritis. This means that blood tests can help guide diagnosis and treatment in some groups of patients. However, a kidney biopsy is still a necessary part of the diagnostic evaluation for most adult patients in whom a medical kidney disease is suspected.<\/p>\n<p>Selvom vores viden om \u00e6tiologi, prognose og behandlingsrespons for nyresygdomme er \u00f8get v\u00e6sentligt, er der fortsat et stort behov forskning p\u00e5 omr\u00e5det, hvis m\u00e5let om individualiseret, personlig medicin skal opn\u00e5s. Derfor er det vigtigt at identificere biomark\u00f8rer, s\u00e5ledes at vi p\u00e5 sigt kan spare udvalgte patienter for at f\u00e5 taget biopsier. Herudover kan biomark\u00f8rer bidrage v\u00e6sentligt til monitorering af behandlingsrespons. Mange af de prim\u00e6re medicinske nyrelidelser optr\u00e6der sj\u00e6ldent og pro-spektiv forskning p\u00e5 omr\u00e5det er derfor udfordret af, at det kan tage mange \u00e5r og kr\u00e6ver nationale\/internationale samarbejder at indsamle tilstr\u00e6kkeligt materiale.<\/p>\n<p>The Danish Nephro Biobank (DNB) will make a significant contribution to both patient care and research in the field of kidney diseases.<\/p>\n<p>The establishment of a clinical biobank will enable the systematic collection of blood, urine, and kidney tissue across regions, ensuring that optimal material for the patient\u2019s own treatment is preserved over time. With the ongoing development of new biomarkers, it is expected that previously collected samples will become relevant for testing, for example, to verify diagnoses and serological status from before treatment began.<br \/>\nOver time, the biobank will provide high-quality material collected over several years\u2014and therefore from a larger number of patients\u2014making it possible to conduct research on otherwise rare kidney diseases.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1692715019860-27376404-d8bd\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Rheumatologic Biobank (DRB)<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1692715019860-27376404-d8bd\"><div class=\"grve-element grve-text\">\r\n\t\t\t<p>In Denmark, at least 75,000 people live with rheumatoid arthritis, psoriatic arthritis, or spondyloarthritis, and another 25,000 live with connective tissue diseases such as systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome. These conditions are chronic, inflammatory, and autoimmune \u2013 and can cause severe joint pain, reduced mobility, and complications such as cardiovascular disease, osteoporosis, and infections. For many patients, the disease therefore leads to both reduced quality of life and shortened life expectancy.<\/p>\n<p>Although biological treatments have significantly improved outcomes for patients with chronic rheumatic diseases since 2000, these therapies are very costly, accounting for around 1 billion DKK of public healthcare spending each year. At the same time, 30\u201340% of new patients experience no effect or suffer side effects from the treatment, and up to half lose its effectiveness over time. As a result, approximately 1,000 Danish patients each year receive expensive but ineffective medication, which has major health as well as economic consequences. This highlights a pressing need for better tools to predict treatment response and to tailor therapy to the individual patient.<\/p>\n<p>To support this development, the nationwide research and quality database DANBIO was established in 2000. Today, it contains clinical data on more than 80,000 patients with inflammatory arthritis \u2013 information that is systematically collected across all rheumatology departments in Denmark.<\/p>\n<p>The Danish Rheumatologic Biobank (DRB) was established on January 1, 2015, with support from the Danish Rheumatism Association and Danish Regions. The first blood sample was collected on May 4 that same year. Samples are collected locally and require close collaboration between rheumatology departments, clinical biochemistry units, and the teams responsible for blood sampling.<\/p>\n<p>The biobank\u2019s biological material is linked with the extensive, high-quality clinical data from DANBIO. Together, this creates a unique framework for Danish research in personalized medicine \u2013 with the potential both to enable earlier diagnosis and to tailor treatment to each individual patient.<\/p>\n<p>To date, 35 research projects and collaborations have been conducted based on the Danish Rheumatologic Biobank, both nationally and locally.<\/p>\n<p>The Danish Rheumatologic Biobank thus contributes to advancing new knowledge, improving treatment, and promoting a more sustainable use of healthcare resources in Denmark.<\/p>\n\r\n\t\t<\/div>\r\n\t<div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1713268874162-bef27eae-eb7d\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Screening Biobank (DScB)<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1713268874162-bef27eae-eb7d\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<p>In January 2021, Danish Regions implemented new guidelines for the Danish cervical cancer screening program. The guidelines mark a paradigm shift in cervical cancer prevention, introducing molecular screening for human papillomavirus (HPV).<\/p>\n<p>Screening samples were previously stored as fixed cytological preparations, but HPV screening requires the storage of liquid-based gynecological cell samples. To support HPV screening and enable quality control, audits, and reassessment of samples at the patient level, the Danish Screening Biobank (DScB) was established.<\/p>\n<p>The purposes of DScB are:<\/p>\n<p>To enable confirmatory HPV tests and additional high-quality analyses in connection with audits following a diagnosis of cervical cancer.<\/p>\n<p>To ensure sufficient material for ongoing quality assurance (QA\/QC) of the screening program.<\/p>\n<p>To enable analyses related to the patient pathway.<\/p>\n<p>In the longer term, the biobank is also intended to support technological advances in HPV screening, as well as the development of new methods that can enhance the secondary prevention of cervical cancer. The goal is to enable a shift from mass screening to more individualized screening.<\/p>\n<p>An important recent development is the introduction of HPV self-testing. Whereas screening samples have primarily been collected by clinicians over the past 50 years, new molecular technologies now make it possible for women to collect the sample themselves at home and send it for analysis to a central laboratory. Since 2023, HPV self-testing has been offered to women who do not respond to the standard screening invitation. However, there are still no internationally established biobank protocols for this type of sample, as they are prepared in a lysis medium rather than a fixation medium. DScB will therefore work purposefully to establish <em>best practice<\/em> for biobanking of HPV self-samples, ensuring that all women receive consistent quality in screening \u2013 whether the sample is collected by a clinician or through self-testing.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1713268830933-351a2ca0-1c6f\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Whole Genome Biobank (DWB)<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1713268830933-351a2ca0-1c6f\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<p>In 2021, it was decided that all material used for whole genome sequencing (WGS) at the National Genome Center (NGC) must be stored and registered as part of the RBGB infrastructure. To support this purpose, the clinical biobank Danish Whole Genome Biobank (DWB) was established<\/p>\n<p>After sequencing, the material is sent to Herlev Hospital for long-term storage, along with the associated data, which are registered in the RBGB database.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/li><li><div class=\"grve-title-wrapper grve-tab-link grve-align-center grve-icon-position-default\" data-rel=\"#1713268913971-57a12be1-a03c\"><div class=\"grve-accordion-arrow grve-svg-heading-color grve-accordion-chevron\">\t\t\t\t<svg width=\"24px\" height=\"24px\" viewbox=\"0 0 24 24\">\r\n\t\t\t\t\t<polygon points=\"18 10.6 12 17 6 10.6 7.5 9 12 13.8 16.5 9\"><\/polygon>\r\n\t\t\t\t<\/svg>\r\n\t\t\t<\/div><h3 class=\"grve-title grve-h5\">The Danish Eye Biobank (D\u00d8B)<\/h3><\/div><div class=\"grve-accordion-content\" id=\"1713268913971-57a12be1-a03c\"><div style=\"height: 20px;\" class=\"grve-empty-space\"><\/div><div class=\"grve-element grve-text\">\r\n\t\t\t<p>The Danish Eye Biobank (D\u00d8B) was established as part of the RBGB infrastructure in 2022. The purpose of the Danish Eye Biobank is:<\/p>\n<ul>\n<li>To ensure systematic registration and storage of clinical eye samples, preserving them for future research.<\/li>\n<li>To create visibility and accessibility of the material through RBGB, so that it can benefit other researchers in the future.<\/li>\n<li>To support projects ranging from completed studies to ongoing and future research initiatives.<\/li>\n<\/ul>\n<p>The Danish Eye Biobank is thus being established as a new, specialized biobank with the potential to become a central resource for research on eye diseases in Denmark.<\/p>\n\r\n\t\t<\/div>\r\n\t<\/div><\/li><\/ul><\/div><\/div><\/div><\/div><\/div><\/div><\/div><div class=\"grve-section grve-row-section grve-container-width grve-padding-top-1x grve-padding-bottom-1x grve-with-bg-transparent\" data-header-color=\"default\"><div class=\"grve-container\"><div class=\"grve-row grve-bookmark grve-columns-gap-default grve-mobile-vertical-gap-30\"><div class=\"grve-column wpb_column grve-bookmark grve-column-1-4  grve-with-bg-transparent wip-box grve-empty-column\"><div class=\"grve-column-wrapper grve-medium-shadow\"><div class=\"grve-column-content\" ><\/div><\/div><\/div><div class=\"grve-column wpb_column grve-bookmark grve-column-1-4  grve-with-bg-transparent grve-empty-column\"><div class=\"grve-column-wrapper\"><div class=\"grve-column-content\" ><\/div><\/div><\/div><div class=\"grve-column wpb_column grve-bookmark grve-column-1-4  grve-with-bg-transparent grve-empty-column\"><div class=\"grve-column-wrapper\"><div class=\"grve-column-content\" ><\/div><\/div><\/div><div class=\"grve-column wpb_column grve-bookmark grve-column-1-4  grve-with-bg-transparent grve-empty-column\"><div class=\"grve-column-wrapper\"><div class=\"grve-column-content\" ><\/div><\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"Om RBGB Introduktion til Regionernes Bio- og GenomBank (RBGB) Regionernes Bio- og GenomBank er den samlede betegnelse for en r\u00e6kke kliniske biobanker indenfor forskellige sygdomsomr\u00e5der, samt en donations- og en forskningsbiobank. Se med i videoen nedenfor, hvor Leif Panduro Jensen (Tidligere formand for styregruppen for RBGB) og Estrid H\u00f8gdall (Direkt\u00f8r for RBGB og professor) fort\u00e6ller [...]","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-139","page","type-page","status-publish","hentry","grve-entry-item"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.rbgb.dk\/en\/wp-json\/wp\/v2\/pages\/139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rbgb.dk\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.rbgb.dk\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.rbgb.dk\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rbgb.dk\/en\/wp-json\/wp\/v2\/comments?post=139"}],"version-history":[{"count":163,"href":"https:\/\/www.rbgb.dk\/en\/wp-json\/wp\/v2\/pages\/139\/revisions"}],"predecessor-version":[{"id":2729,"href":"https:\/\/www.rbgb.dk\/en\/wp-json\/wp\/v2\/pages\/139\/revisions\/2729"}],"wp:attachment":[{"href":"https:\/\/www.rbgb.dk\/en\/wp-json\/wp\/v2\/media?parent=139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}